Myocardial fibrosis: Current aspects of the problem

Por V N Karetnikova, V V Kashtalap, S N Kosareva, O L Barbarash
Publicado em 2017-01-01

INTERLEUKIN 33 AND FIBROSIS: PATHOGENESIS UPDATED

Por E. G. Uchasova, O. V. Gruzdeva, Yu. A. Dileva, V. N. Karetnikova
Publicado em 2018-06-01

RELATION OF THE MARKERS OF MYOCARDIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION WITH STRUCTURAL AND FUNCTIONAL PARAMETERS OF THE LUNGS IN MYOCARDIAL INFARCTION PATIENTS

Por O. M. Polikutina, Y. S. Slepynina, E. D. Bazdyrev, V. N. Karetnikova, O. L. Barbarach
Publicado em 2018-04-01

THE OUTCOMES OF STEMI IN PATIENTS WITH COPD IN KEMEROVO REGION

Por O. M. Polikutina, Yu. S. Slepynina, E. D. Bazdyrev, V. N. Karetnikova, O. L. Barbarash
Publicado em 2014-07-01

Impact of chronic obstructive pulmonary disease on one-year prognosis in patients with ST-segment elevation myocardial infarction

Por O M Polikutina, Yu S Slepynina, E D Bazdyrev, V N Karetnikova, O L Barbarach
Publicado em 2015-09-01

Prevalence of electrocardiographic changes in Kemerovo region according to the data of the ESSE-RF study

Por O. M. Polikutina, Yu. S. Slepynina, V. N. Karetnikova, T. A. Mulerova, E. V. Indukaeva, G. V. Artamonova
Publicado em 2019-03-01

Pro-inflammatory cytokines and depression in myocardial infarction

Por O. L. Barbarash, N. B. Lebedeva, V. N. Karetnikova, S. A. Berns, V. V. Kashtalap, L. S. Barbarash
Publicado em 2011-04-01

IMPLEMENTATION OF THE GRACE SCORE IN ACUTE CORONARY SYNDROME WITH RENAL DYSFUNCTION

Por M. V. Zykov, V. V. Kashtalap, I. S. Bykova, O. V. Gruzdeva, V. N. Karetnikova, О. L. Barbarash
Publicado em 2017-12-01

SPECIFICS OF THE LEFT HEART CHAMBERS EARLY POST INFARCTION REMODELING IN COMORBID COPD OF MILD AND MODERATE SEVERITY

Por O. M. Polikutina, Yu. S. Slepynina, E. D. Bazdyrev, E. G. Vasyutinskaya, V. N. Karetnikova, O. L. Barbarash
Publicado em 2015-12-01

COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS

Por M. V. Zykov, O. L. Barbarash, D. S. Zykova, V. N. Karetnikova, E. V. Tavlueva, V. V. Kashtalap
Publicado em 2012-02-01

SPECIAL FEATURES OF REHABILITATION AND OUTCOME PREDICTION IN MYOCARDIAL INFARCTION COMPLICATED BY ARRHYTHMIAS

Por N. I. Tarasov, V. N. Karetnikova, E. V. Malahovich, B. Z. Zhaleyev, E. N. Gulyayeva, O. L. Barbarash
Publicado em 2001-06-01

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION

Por O. L. Barbarash, O. V. Gruzdeva, O. E. Akbasheva, E. I. Palicheva, E. G. Uchasova, V. N. Karetnikova, T. S. Fedorova
Publicado em 2014-03-01

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction

Por A. V. Osokina, V. N. Karetnikova, S. N. Ryzhenkova, O. M. Polikutina, A. V. Ivanova, O. V. Gruzdeva, O. L. Barbarash
Publicado em 2021-07-01

N-terminal propeptide of type III procollagen for predicting diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction

Por A. V. Osokina, V. N. Karetnikova, O. M. Polikutina, A. V. Ivanova, O. E. Avramenko, O, V. Gruzdeva, O. L. Barbarash
Publicado em 2021-02-01

In-hospital changes of echocardiographic parameters and their relationship with the procollagen I C-terminal propeptide in patients with myocardial infarction and preserved left ve...

Por A. V. Osokina, V. N. Karetnikova, O. V. Polikutina, A. V. Ivanova, O. V. Gruzdeva, S. A. Ryzhenkova, T. P. Artemova, O. L. Barbarash
Publicado em 2020-03-01

CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION

Por M. V. Zykov, V. V. Kashtalap, I. S. Bykova, O. N. Khryachkova, V. V. Kalaeva, K. S. Shafranskaya, V. N. Karetnikova, O. L. Barbarash
Publicado em 2015-11-01

RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION

Por O. V. Gruzdeva, O. E. Akbasheva, D. A. Borodkina, V. N. Karetnikova, Yu. A. Dyleva, A. N. Kokov, T. S. Fedorova, O. L. Barbarash
Publicado em 2015-04-01

PROGNOSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION, IN REGARD TO THE PRESENCE OF TYPE 2 DIABETES MELLITUS AND SELECTED TREATMENT STRATEGY IN THE ACUTE PERIOD

Por Yu. A. Belen’kova, E. V. Tavlueva, V. N. Karetnikova, M. V. Zykov, V. V. Kashtalap, V. N. Ganyukov, O. L. Barbarash
Publicado em 2012-10-01

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE

Por K. S. Shafranskaya, M. V. Zykov, V. V. Kashtalap, O. K. Kuzmina, I. S. Bykova, V. N. Karetnikova, A. N. Sumin, S. V. Ivanov S, O. L. Barbarash
Publicado em 2015-03-01

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction

Por O. L. Barbarash, O. V. Gruzdeva, O. E. Akbasheva, T. S. Fedorova, A. A. Silonova, E. I. Palicheva, E. G. Uchasova, V. N. Karetnikova, V. V. Kashtalap
Publicado em 2013-06-01